• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭中“相当大量”的青霉素G治疗

"Comparably massive" penicillin G therapy in renal failure.

作者信息

Bryan C S, Stone W J

出版信息

Ann Intern Med. 1975 Feb;82(2):189-95. doi: 10.7326/0003-4819-82-2-189.

DOI:10.7326/0003-4819-82-2-189
PMID:1115440
Abstract

Impairment of penicillin G excretion in renal failure may result in life-threatening, dose-related toxicity. We report a method for achieving a desired mean serum penicillin G concentration in patients with renal failure, with minimal risk of both undertreatment and drug toxicity. The method is based on the linear relation between the total plasma clearance of penicillin G (Cpen) and the endogenous creatinine clearance. The daily maintenance dose of penicillin G (units) is defined by the product, Cpen (ml/min) times desired mean serum penicillin G concentration (mug/ml) times 2300. Application of this method to patients with various degrees of renal impairment by either constant-rate infusion or intermittent infusion gave serum penicillin G concentrations within the desired range in all but 1 of 15 instances. On the basis of these observations, practical guidelines for "comparably massive" penicillin G therapy are suggested.

摘要

肾衰竭时青霉素G排泄受损可能导致危及生命的剂量相关毒性。我们报告一种方法,可使肾衰竭患者达到期望的平均血清青霉素G浓度,同时将治疗不足和药物毒性的风险降至最低。该方法基于青霉素G的总血浆清除率(Cpen)与内生肌酐清除率之间的线性关系。青霉素G的每日维持剂量(单位)由Cpen(毫升/分钟)乘以期望的平均血清青霉素G浓度(微克/毫升)再乘以2300得出。通过恒速输注或间歇输注将该方法应用于不同程度肾功能损害的患者,15例中除1例外,其余患者的血清青霉素G浓度均在期望范围内。基于这些观察结果,提出了“相当大量”青霉素G治疗的实用指南。

相似文献

1
"Comparably massive" penicillin G therapy in renal failure.肾衰竭中“相当大量”的青霉素G治疗
Ann Intern Med. 1975 Feb;82(2):189-95. doi: 10.7326/0003-4819-82-2-189.
2
Letter: Penicillin dose and creatinine clearance.信件:青霉素剂量与肌酐清除率
Ann Intern Med. 1976 Jun;84(6):754. doi: 10.7326/0003-4819-84-6-754_1.
3
Pharmacokinetics of cefepime in subjects with renal insufficiency.头孢吡肟在肾功能不全受试者中的药代动力学。
Clin Pharmacol Ther. 1990 Sep;48(3):268-76. doi: 10.1038/clpt.1990.149.
4
Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations?感染性心内膜炎患者的青霉素G治疗——标准剂量能否产生治疗性血浆浓度?
Basic Clin Pharmacol Toxicol. 2017 Feb;120(2):179-186. doi: 10.1111/bcpt.12661. Epub 2016 Sep 16.
5
Penicillin dosing for pneumococcal pneumonia.肺炎球菌肺炎的青霉素给药剂量
Chest. 1997 Dec;112(6):1657-64. doi: 10.1378/chest.112.6.1657.
6
The kinetics of aminosidine in renal patients with different degrees of renal failure.不同程度肾衰竭肾病患者中丁胺卡那霉素的动力学
Clin Nephrol. 1975 Jul;4(1):23-4.
7
Bretylium kinetics in renal insufficiency.肾功能不全时溴苄铵的药代动力学
Clin Pharmacol Ther. 1983 Feb;33(2):144-50. doi: 10.1038/clpt.1983.22.
8
Urinary tract infection and oral penicillin G.尿路感染与口服青霉素G
J Clin Pathol. 1972 Jan;25(1):73-5. doi: 10.1136/jcp.25.1.73.
9
Pharmacokinetics of sulbenicillin, a new broad-spectrum semisynthetic penicillin.新广谱半合成青霉素磺苄西林的药代动力学
Clin Pharmacol Ther. 1975 Mar;17(3):339-47. doi: 10.1002/cpt1975173339.
10
Blood level kinetics of penicillin G following high-dosage parenteral administration.大剂量胃肠外给药后青霉素G的血药浓度动力学
Dtsch Med Wochenschr. 1971 Aug 27;96(35):1393-8. doi: 10.1055/s-0028-1110149.

引用本文的文献

1
Nephroprotective Effect of the Leaf Extract of remota Benth Against Gentamicin-Induced Nephrotoxicity in Swiss Albino Mice.远距滨藜叶提取物对庆大霉素诱导的瑞士白化小鼠肾毒性的肾保护作用
J Exp Pharmacol. 2024 Mar 26;16:159-171. doi: 10.2147/JEP.S455226. eCollection 2024.
2
Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis.感染性心内膜炎患者青霉素G的群体药代动力学分析及给药方案优化
J Pharm Health Care Sci. 2016 Apr 5;2:9. doi: 10.1186/s40780-016-0043-x. eCollection 2016.
3
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
持续静脉-静脉血液滤过期间持续输注β-内酰胺类抗生素治疗耐药革兰阴性菌感染
Ann Pharmacother. 2009 Jul;43(7):1324-37. doi: 10.1345/aph.1L638. Epub 2009 Jul 7.
4
Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.接受血液透析患者的药物治疗。临床药代动力学考量
Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003.
5
Mecillinam in patients on haemodialysis.血液透析患者使用美西林
Br J Clin Pharmacol. 1980 Aug;10(2):177-80. doi: 10.1111/j.1365-2125.1980.tb01741.x.
6
Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.药物动力学特性的差异:对肾衰竭患者选用特定药物的意义,特别强调抗生素和β-肾上腺素能受体阻滞剂。
Clin Pharmacokinet. 1980 Sep-Oct;5(5):441-64. doi: 10.2165/00003088-198005050-00003.
7
Pharmacokinetics and pharmacodynamics in critically ill patients.危重症患者的药代动力学和药效学
World J Surg. 1987 Apr;11(2):210-7. doi: 10.1007/BF01656404.
8
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学
Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.
9
Pharmacokinetics of nafcillin in patients with renal failure.肾衰竭患者中萘夫西林的药代动力学。
Antimicrob Agents Chemother. 1977 Jul;12(1):98-101. doi: 10.1128/AAC.12.1.98.
10
Pharmacokinetics of the penicillins in man.青霉素在人体内的药代动力学。
Clin Pharmacokinet. 1976;1(4):297-308. doi: 10.2165/00003088-197601040-00004.